Cartalax Lyophilized Peptide Powder

Cartalax is a synthetic tripeptide commonly described by the amino acid sequence Ala-Glu-Asp (AED). It has been discussed in research involving cartilage tissue, chondrocyte function, and extracellular matrix metabolism.

Cartalax Lyophilized Peptide Powder provides the peptide in a freeze-dried format for research and material preparation. Its defined three-amino-acid sequence distinguishes it from longer peptides and complex peptide mixtures, making product identity and formulation requirements important considerations when selecting a raw material for a specific research project.

For laboratories and peptide-related businesses, Cartalax may be relevant to studies exploring cartilage-associated biological pathways, including extracellular matrix synthesis and degradation. The effects and mechanisms of this peptide should be evaluated against the available scientific evidence and the requirements of each research model.

JinBei supplies peptide-related chemical raw materials from Shanghai, China, serving customers involved in research material sourcing and specialty chemical distribution.

Advantage

Cartalax Lyophilized Peptide Powder can regulate the gene expression of chondrocytes, promoting the synthesis of type II collagen and aggrecan, inhibiting matrix degrading enzymes, alleviating chondral inflammation, inhibiting chondrocyte apoptosis, delaying chondral degenerative damage, and maintaining the homeostasis of articular cartilage.

Product function

Promote the synthesis of cartilage matrix

Upregulate the Sox9 and COL2A1 genes to stimulate the production of type II collagen and aggrecan by chondrocytes, thicken and repair the extracellular matrix of chondrocytes, and improve the thinning of cartilage.

Inhibit the breakdown of cartilage matrix

Reduce MMP (matrix metalloproteinase) levels, thereby decreasing the breakdown of collagen and proteoglycans; alleviate local low-level inflammation in the joint, and balance the synthesis and degradation of cartilage metabolism.

Inhibit matrix decomposition

Reduce MMP levels, thereby minimizing collagen rupture and proteoglycan loss.

Maintain cartilage homeostasis

Balance synthesis and degradation processes, and protect the integrity of the cartilage matrix.

Improve the aging state of cells

Inhibit the apoptosis of chondrocytes and improve the aging-related phenotypes.

Important usage guidelines

1. Storage Requirements

Long-term storage: -20℃ in a dark, dry, and refrigerated environment; after reconstitution, aliquot the solution into small doses for single use, avoid repeated freezing and thawing, to prevent the loss of activity and degradation of the polypeptide; before opening, allow it to warm up and prevent moisture absorption and humidity.

2. Observation of adverse reactions:

For the injectable formulation, there may be mild local redness and irritation; for the oral formulation, a few cases may experience temporary gastrointestinal discomfort. In case of allergy or persistent joint swelling and pain, immediately stop using it and seek medical attention.

3.Adverse Reaction Monitoring

The injectable formulation may cause mild local redness and irritation; the oral formulation may cause temporary gastrointestinal discomfort in a few cases. If an allergic reaction or persistent joint swelling and pain occurs, stop the use immediately and seek medical attention.

4. Co-administration Warning

When used in combination with anti-inflammatory drugs, hormones, or other polypeptides, insufficient interaction data is available. It is necessary to assess in advance and it is not recommended to arbitrarily stack them.

Maintenance Points

The Cartalax Lyophilized Peptide Powder should be stored at -20℃ in a dark place under a dry condition. It is strictly prohibited to repeatedly freeze and thaw. After reconstitution, it is recommended to prepare it immediately for use. Sterile operation should be carried out to avoid contamination, ensuring the activity of the polypeptide.

Frequently Asked Questions

Q1: What is Cartalax Lyophilized Peptide Powder?

Cartalax is a synthetic tripeptide commonly identified by the amino acid sequence Ala-Glu-Asp (AED). This product is supplied in freeze-dried powder form for research-related applications.

Q2: What research areas are associated with Cartalax?

Cartalax has been discussed in relation to cartilage biology, chondrocyte function, and extracellular matrix metabolism. Specific biological effects depend on the evidence available for the particular application and research model.

Q3: How should Cartalax powder be stored?

Follow the storage conditions specified for the actual product. If −20°C storage is required by the product specification, maintain the material under the stated temperature and environmental conditions.

Q4: Does JinBei support different order quantities?

JinBei can discuss sample requests, small-batch orders, and bulk supply according to product availability and the customer's requirements.

Q5: Can JinBei discuss customized peptide raw material requirements?

JinBei can discuss peptide-related sourcing and customization requirements, subject to technical feasibility, product specifications, and production arrangements.